$MNKD while we sit and wait for United to do its thing with Tyvaso DPI & would like to see Mannkind and Mike make announcements regarding material events being working on, implemented and executed by Mannkind to create value for shareholders. That would include Afrezza Pediatric Trial news, Receptor Life Sciences news, partnership news and other changes being considered and executed to create near term and long term value for shareholders. I am all in and very confidant United will over achieve and over deliver when it comes to Tyvaso DPI, just looking to see Mannkind do the same for their own internal programs.